Monday, June 1, 2009

Hitting where it hurts

Exploiting cancer cell 'addiction' may lead to new therapies

A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The study from MGH Cancer Center researchers identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously treatment resistant cancer.

 

Link to full Cell Press release.

Katie Marquedant, 617 726-0337, kmarquedant@partners.org

Browse the Entire Newsroom Archive

Back to Top